Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

December 31, 2007

Conditions
Malignant Melanoma
Interventions
DRUG

imexon

DRUG

DTIC

Trial Locations (11)

12208

US Oncology Albany, New York Oncology, Albany

23502

US Oncology, Virginia Oncology Assoc, Norfolk

29615

US Oncology Greenville, Cancer Centers of the Carolinas, Greenville

34761

US Oncology Orlando, Cancer Centers of FL, Ocoee

45409

US Oncology Kettering, Kettering

75702

US Oncology, Tyler Cancer Center, Tyler

80010

University of CO Anschutz Cancer Pavilion, Aurora

84112

Investigational Site 012, Salt Lake City

90033

Investigational Site 009, Los Angeles

90404

Investigational Site 002, Santa Monica

99218

US Oncology Spokane, Cancer Care Northwest, Spokane

Sponsors
All Listed Sponsors
lead

AmpliMed Corporation

INDUSTRY